title: Risk of Anaphylaxis With Intravenous Iron Products.
authors.affiliation: Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Cunlin
authors.initials: C
authors.lastname: Wang
authors.affiliation: ACUMEN LLC, Burlingame, California.
authors.forename: Sarah
authors.initials: S
authors.lastname: Wong
authors.affiliation: Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: David J
authors.initials: DJ
authors.lastname: Graham
mesh_terms: D000707:Anaphylaxis / Q000209:etiology*; D005260:Female; D005290:Ferric Compounds / Q000009:adverse effects*; D052203:Ferrosoferric Oxide / Q000009:adverse effects*; D005937:Glucaric Acid / Q000009:adverse effects*; D005942:Gluconates / Q000009:adverse effects*; D006801:Humans; D007505:Iron-Dextran Complex / Q000009:adverse effects*; D008297:Male
chemical_list: D005290:Ferric Compounds; D005942:Gluconates; D007505:Iron-Dextran Complex; D005937:Glucaric Acid; D052203:Ferrosoferric Oxide